Photodynamic efficacy of hypericin targeted by two delivery techniques to hepatocellular carcinoma cells

被引:12
|
作者
Fadel, Maha [2 ]
Kassab, Kawser [3 ]
Youssef, Tareq [1 ]
机构
[1] Cairo Univ, Photobiosci Lab, Div Photochem & Photobiol, NILES, Giza 12613, Egypt
[2] Cairo Univ, Pharmaceut Technol Lab, Med Laser Applicat Dept, NILES, Giza 12613, Egypt
[3] Cairo Univ, Cell Photosensitizat Lab, Med Laser Applicat Dept, NILES, Giza 12613, Egypt
关键词
Photodynamic therapy; Hypericin; Drug carrier; Anti-hepatocyte specific antigen; Liposomes; Hepatocellular carcinoma; ANTIVIRAL AGENT HYPERICIN; IN-VITRO; HUMAN GLIOBLASTOMA; SINGLET OXYGEN; THERAPY; FLUORESCENCE; CANCER; PHOTOSENSITIZATION; PHOTOIMMUNOTHERAPY; LOCALIZATION;
D O I
10.1007/s10103-010-0787-8
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The photocytotoxic effect of hypericin (Hyp) targeted by two different delivery techniques, namely, liposomes and anti-hepatocyte specific antigen (anti-HSA) was investigated. Optical absorption and steady-state fluorescence were used to analyze the conjugation of Hyp with anti-HSA model and to evaluate the encapsulation capacity and drug release in a liposome model. Particle size and thermal analysis of the prepared liposomes were performed using laser-light scattering and differential scanning calorimetry (DSC), respectively. Viability study of HepG2 cells exposed to Hyp in the two delivery systems, in the dark and following visible light irradiation, was performed in comparison to free Hyp. The intracellular uptake and localization of Hyp in HepG2 cells were analyzed by means of spectrofluorometry and fluorescence microscopy. Spectroscopic measurements demonstrated that Hyp binds to anti-HSA in its monomeric form. The photocytotoxic effect of Hyp depended clearly on the form of Hyp administered, either in free form, loaded into liposomes or conjugated with anti-HSA. While liposomes loaded with Hyp (Lip-Hyp) did not induce significant phototoxicity, both free Hyp or anti-HSA-Hyp inflicted substantial cell mortality, after photoirradiation. The intracellular uptake of Lip-Hyp by HepG2 cells was estimated to be 20% less compared to free Hyp or anti-HSA-Hyp. In spite of the equal uptake of both free Hyp and anti-HSA-Hyp, HepG2 cells demonstrated a relatively higher mortality with anti-HSA-Hyp compared to free Hyp.
引用
收藏
页码:675 / 683
页数:9
相关论文
共 50 条
  • [21] In vivo targeted gene delivery by cationic nanoparticles for treatment of hepatocellular carcinoma
    Diez, Sonsoles
    Navarro, Gemma
    de ILarduya, Conchita Tros
    JOURNAL OF GENE MEDICINE, 2009, 11 (01): : 38 - 45
  • [22] Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma
    Jaleh Varshosaz
    Maryam Farzan
    World Journal of Gastroenterology, 2015, (42) : 12022 - 12041
  • [23] Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma
    Varshosaz, Jaleh
    Farzan, Maryam
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (42) : 12022 - 12041
  • [24] Efficacy and Prognostic Factors of Sorafenib Targeted Therapy for Advanced Hepatocellular Carcinoma
    Sun Long
    Yang Shiwei
    Fang Qing
    Liu Ping
    Zhang Rongjie
    Hu Chunfang
    Hao Yingxue
    LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (01): : 120 - 125
  • [25] Strategies to optimize siRNA delivery to hepatocellular carcinoma cells
    Scarabel, Lucia
    Perrone, Francesca
    Garziera, Marica
    Farra, Rossella
    Grassi, Mario
    Musiani, Francesco
    Spena, Concetta Russo
    Salis, Barbara
    De Stefano, Lucia
    Toffoli, Giuseppe
    Rizzolio, Flavio
    Tonon, Federica
    Abrami, Michela
    Chiarappa, Gianluca
    Pozzato, Gabriele
    Forte, Giancarlo
    Grassi, Gabriele
    Dapas, Barbara
    EXPERT OPINION ON DRUG DELIVERY, 2017, 14 (06) : 797 - 810
  • [26] PHOTODYNAMIC EFFECTS OF CURCUMIN ON PEDIATRIC HEPATOBLASTOMA AND HEPATOCELLULAR CARCINOMA CELLS LINES
    Bortel, N.
    Armeanu, S.
    Schmid, E.
    Warmann, S.
    Fuchs, J.
    Ellerkamp, V.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S309 - S309
  • [27] PEGylated trimethylchitosan emulsomes conjugated to octreotide for targeted delivery of sorafenib to hepatocellular carcinoma cells of HepG2
    Varshosaz, Jaleh
    Raghami, Fatemeh
    Rostami, Mahboubeh
    Jahanian, Ali
    JOURNAL OF LIPOSOME RESEARCH, 2019, 29 (04) : 383 - 398
  • [28] In vitro and in vivo targeted delivery of photosensitizers to the tumor cells for enhanced photodynamic effects
    Gupta, Seema
    Dwarakanath, Bilikere S.
    Chaudhury, N. K.
    Mishra, Anil K.
    Muralidhar, K.
    Jain, Viney
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2011, 7 (03) : 314 - 324
  • [29] Ligand-mediated Targeted Drug Delivery Approaches against Hepatocellular Carcinoma
    Singh, Amrita
    Mishra, Sudhanshu
    Sharma, Saurabh
    Ojha, Smriti
    Yagnik, Sunil
    Pandey, Sudhi
    CURRENT CANCER DRUG TARGETS, 2023, 23 (11) : 879 - 888
  • [30] N-acetylgalactosamine-decorated nanoliposomes for targeted delivery of paclitaxel to hepatocellular carcinoma
    Li, Tingshen
    Yu, Peng
    Chen, Yihao
    Sun, Baoying
    Dong, Peijie
    Zhu, Tao
    Meng, Xin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 222